Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 220

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner

Open access
Maleszewska, Monika, Moonen, Jan-Renier A.J., Huijkman, Nicolette, van de Sluis, Bart, Krenning, Guido, Harmsen, Martin C.·2013·Immunobiology

Abstract

Endothelial to mesenchymal transition (EndMT) contributes to fibrotic diseases. The main inducer of EndMT is TGFβ signaling. TGFβ2 is the dominant isoform in the physiological embryonic EndMT, but its role in the pathological EndMT in the context of inflammatory co-stimulation is not known. The aim of this study was to investigate TGFβ2-induced EndMT in the context of inflammatory IL-1β signaling. Co-stimulation with IL-1β and TGFβ2, but not TGFβ1, caused synergistic induction of EndMT. Also, TGFβ2 was the only TGFβ isoform that was progressively upregulated during EndMT. External IL-1β stimulation was dispensable once EndMT was induced. The inflammatory transcription factor NFκB was upregulated in an additive manner by IL-1β and TGFβ2 co-stimulation. Co-stimulation also led to the nuclear translocation of NFκB which was sustained over long-term treatment. Activation of NFκB was indispensable for the co-induction of EndMT. Our data suggest that the microenvironment at the verge between inflammation (IL-1β) and tissue remodeling (TGFβ2) can strongly promote the process of EndMT. Therefore our findings provide new insights into the mechanisms of pathological EndMT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.imbio.2012.05.026

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 48

  1. Arciniegas, 2008, Possible role of NFkappaB in the embryonic vascular remodeling and the endothelial mesenchymal transition process, Cell Adhes. Migr., 2, 17, 10.4161/cam.2.1.5789 · DOI
  2. Arciniegas, 1992, Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro, J. Cell Sci., 103, 521, 10.1242/jcs.103.2.521 · DOI · Paper page
  3. Armstrong, 2004, Heart valve development: endothelial cell signaling and differentiation, Circ. Res., 95, 459, 10.1161/01.RES.0000141146.95728.da · DOI · Paper page
  4. Azhar, 2009, Ligand-specific function of transforming growth factor beta in epithelial–mesenchymal transition in heart development, Dev. Dyn., 238, 431, 10.1002/dvdy.21854 · DOI
  5. Barbieri, 2008, Suppressing PTEN activity by tobacco smoke plus interleukin-1beta modulates dissociation of VE-cadherin/beta-catenin complexes in endothelium, Arterioscler. Thromb. Vasc. Biol., 28, 732, 10.1161/ATVBAHA.107.159434 · DOI
  6. Barbieri, 2007, Tobacco smoke cooperates with interleukin-1beta to alter beta-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo, FASEB J., 21, 1831, 10.1096/fj.06-7557com · DOI
  7. Basile, 2011, Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury, Am. J. Physiol. Renal Physiol., 300, F721, 10.1152/ajprenal.00546.2010 · DOI · Paper page
  8. Boyer, 1999, TGFbeta2 and TGFbeta3 have separate and sequential activities during epithelial–mesenchymal cell transformation in the embryonic heart, Dev. Biol., 208, 530, 10.1006/dbio.1999.9211 · DOI · Paper page
  9. Bujak, 2008, Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling, Am. J. Pathol., 173, 57, 10.2353/ajpath.2008.070974 · DOI · Paper page
  10. Bujak, 2009, The role of IL-1 in the pathogenesis of heart disease, Arch. Immunol. Ther. Exp. (Warsz), 57, 165, 10.1007/s00005-009-0024-y · DOI · Paper page
  11. Burmester, 1993, Characterization of distinct functional domains of transforming growth factor beta, Proc. Natl. Acad. Sci. U.S.A., 90, 8628, 10.1073/pnas.90.18.8628 · doi:10.1073/pnas.90.18.8628
  12. Camenisch, 2002, Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis, Dev. Biol., 248, 170, 10.1006/dbio.2002.0731 · DOI · Paper page
  13. Cano, 2000, The transcription factor snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression, Nat. Cell Biol., 2, 76, 10.1038/35000025 · DOI · Paper page
  14. Chaudhuri, 2007, Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis, J. Cutan. Pathol., 34, 146, 10.1111/j.1600-0560.2006.00584.x · DOI
  15. Chimal-Monroy, 1997, Differential effects of transforming growth factors beta 1, beta 2, beta 3 and beta 5 on chondrogenesis in mouse limb bud mesenchymal cells, Int. J. Dev. Biol., 41, 91
  16. Fleenor, 2011, Replicative aging induces endothelial to mesenchymal transition in human aortic endothelial cells: potential role of inflammation, J. Vasc. Res., 49, 59, 10.1159/000329681 · DOI
  17. Frid, 2002, Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis, Circ. Res., 90, 1189, 10.1161/01.RES.0000021432.70309.28 · DOI · Paper page
  18. Goumans, 2003, Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling, Mol. Cell, 12, 817, 10.1016/S1097-2765(03)00386-1 · DOI · Paper page
  19. Hashimoto, 2010, Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis, Am. J. Respir. Cell Mol. Biol., 43, 161, 10.1165/rcmb.2009-0031OC · DOI · Paper page
  20. Hinck, 1996, Transforming growth factor beta 1: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor beta 2, Biochemistry, 35, 8517, 10.1021/bi9604946 · DOI · Paper page
  21. Ishisaki, 2003, Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells, J. Biol. Chem., 278, 1303, 10.1074/jbc.M207329200 · DOI
  22. Jennings, 1988, Comparison of the biological actions of TGF beta-1 and TGF beta-2: differential activity in endothelial cells, J. Cell. Physiol., 137, 167, 10.1002/jcp.1041370120 · DOI · Paper page
  23. Kanaji, 2011, Inflammatory cytokines regulate endothelial cell survival and tissue repair functions via NF-kappaB signaling, J. Inflamm. Res., 4, 127
  24. Kokudo, 2008, Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells, J. Cell Sci., 121, 3317, 10.1242/jcs.028282 · DOI · Paper page
  25. Krenning, 2008, Vascular smooth muscle cells for use in vascular tissue engineering obtained by endothelial-to-mesenchymal transdifferentiation (EnMT) on collagen matrices, Biomaterials, 29, 3703, 10.1016/j.biomaterials.2008.05.034 · DOI
  26. Labelle, 2011, Direct signaling between platelets and cancer cells induces an epithelial–mesenchymal-like transition and promotes metastasis, Cancer Cell, 20, 576, 10.1016/j.ccr.2011.09.009 · DOI · Paper page
  27. Liebner, 2004, Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse, J. Cell Biol., 166, 359, 10.1083/jcb.200403050 · DOI · Paper page
  28. Medici, 2011, Transforming growth factor-beta2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling, Biochem. J., 437, 515, 10.1042/BJ20101500 · DOI · Paper page
  29. Mercado-Pimentel, 2007, Multiple transforming growth factor-beta isoforms and receptors function during epithelial–mesenchymal cell transformation in the embryonic heart, Cells Tissues Organs, 185, 146, 10.1159/000101315 · DOI
  30. Micalizzi, 2010, Epithelial–mesenchymal transition in cancer: parallels between normal development and tumor progression, J. Mammary Gland Biol. Neoplasia, 15, 117, 10.1007/s10911-010-9178-9 · DOI · Paper page
  31. Moonen, 2010, Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny, Cardiovasc. Res., 86, 506, 10.1093/cvr/cvq012 · DOI
  32. Ottmann, 1988, Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells, J. Immunol., 140, 2661, 10.4049/jimmunol.140.8.2661 · DOI · Paper page
  33. Paranya, 2001, Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro, Am. J. Pathol., 159, 1335, 10.1016/S0002-9440(10)62520-5 · DOI · Paper page
  34. Potenta, 2008, The role of endothelial-to-mesenchymal transition in cancer progression, Br. J. Cancer, 99, 1375, 10.1038/sj.bjc.6604662 · DOI · Paper page
  35. Qian, 1994, Characterization of mutated transforming growth factor-beta s which possess unique biological properties, Biochemistry, 33, 12298, 10.1021/bi00206a037 · doi:10.1021/bi00206a037
  36. Qian, 1996, Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule, J. Biol. Chem., 271, 30656, 10.1074/jbc.271.48.30656 · DOI
  37. Rieder, 2011, Inflammation-induced endothelial-to-mesenchymal transition a novel mechanism of intestinal fibrosis, Am. J. Pathol., 179, 2660, 10.1016/j.ajpath.2011.07.042 · DOI · Paper page
  38. Romano, 2000, Slug is an essential target of TGFbeta2 signaling in the developing chicken heart, Dev. Biol., 223, 91, 10.1006/dbio.2000.9750 · DOI · Paper page
  39. Romano, 1999, Slug is a mediator of epithelial–mesenchymal cell transformation in the developing chicken heart, Dev. Biol., 212, 243, 10.1006/dbio.1999.9339 · DOI
  40. Schoemaker, 2002, Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis, J. Hepatol., 36, 742, 10.1016/S0168-8278(02)00063-6 · DOI
  41. Stables, 2011, Transcriptomic analyses of murine resolution-phase macrophages, Blood, 118, e192, 10.1182/blood-2011-04-345330 · DOI · Paper page
  42. Tavares, 2006, TGF beta-mediated RhoA expression is necessary for epithelial–mesenchymal transition in the embryonic chick heart, Dev. Dyn., 235, 1589, 10.1002/dvdy.20771 · DOI
  43. Wang, 2011, miR-200a prevents renal fibrogenesis through repression of TGF-beta2 expression, Diabetes, 60, 280, 10.2337/db10-0892 · DOI · Paper page
  44. Webb, 1994, Transforming growth factor beta isoform 2-specific high affinity binding to native alpha 2-macroglobulin, Chimeras identify a sequence that determines affinity for native but not activated alpha 2-macroglobulin, J. Biol. Chem., 269, 30402, 10.1016/S0021-9258(18)43827-6 · DOI
  45. Zeisberg, 2007, Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts, Cancer Res., 67, 10123, 10.1158/0008-5472.CAN-07-3127 · DOI · Paper page
  46. Zeisberg, 2008, Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition, J. Am. Soc. Nephrol., 19, 2282, 10.1681/ASN.2008050513 · DOI · Paper page
  47. Zeisberg, 2007, Endothelial-to-mesenchymal transition contributes to cardiac fibrosis, Nat. Med., 13, 952, 10.1038/nm1613 · DOI · Paper page
  48. Zhao, 2011, Cardiac pressure overload hypertrophy is differentially regulated by {beta}-adrenergic receptors, Am. J. Physiol. Heart Circ. Physiol., 301, H1461, 10.1152/ajpheart.00453.2010 · DOI

Cited by

See all 220

Metadata

Authors
Maleszewska, M., Moonen, J.-R. A. J., Huijkman, N., van de Sluis, B., Krenning, G., & Harmsen, M. C.
Venue
Immunobiology
Publisher
Elsevier BV
Published
2013-04
Volume
218
Issue
4
Pages
443-454
ISSN
0171-2985 (ISSN-L)
OpenAlex
W1981348175
Cited by
220
References
2
FWCI
3.02
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
  • Dutch Government (FES0908)
  • Groningen University Institute for Drug Exploration (GUIDE)
  • ZonMW/NWO Innovational Research Incentive (916.11.022)
  • Jan Kornelis de Cock Foundation (JRM)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner. https://app.cochat.ai/papers/10.1016/j.imbio.2012.05.026
The paper
Maleszewska, M., Moonen, J.-R. A. J., Huijkman, N., van de Sluis, B., Krenning, G., & Harmsen, M. C. (2013). IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner. Immunobiology. https://doi.org/10.1016/j.imbio.2012.05.026

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.